Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09AIT
|
|||
| Former ID |
DIB002872
|
|||
| Drug Name |
BHT-3201
|
|||
| Indication | Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 1 | [1] | |
| Company |
Bayhill therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00453375) Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.